Danevych.Law team (represented by of Borys Danevych and Anastasiia Filipiuk) acted as a counsel on Ukraine in a multi-jurisdictional project advising one of the leading global suppliers of dental, medical and animal health technologies on legal and compliance aspects of interactions with and transfers of value to healthcare professionals. The advice covered anti-corruption and advertising legislation, practice of its application and its implications on the company's activities.

Borys Danevych and Anastasiia Filipiuk advised a european consultancy focused on pharma industry on business ethics and compliance matters in the course of setting up the Ukrainian subsidiary. Danevych.Law assisted the Client with implementation of local Compliance framework, as well as trained its local team on business conduct expected by international big pharma.

Borys Danevych and Anastasiia Filipiuk advised a global top 10 biopharmaceutical company on various matters related to procurement of innovative medicines through an international organization contracted by the Ministry of Health of Ukraine. The advice covered jurisdictional, contractual, regulatory and customs matters.
Introduction of medicines and medical devices procurement through specialized international organizations back in 2015 significantly increased transparency and efficiency of public spendings in the area.  

In 2018 Danevych.Law team led by partner Borys Danevych along with associates Artem Grudinin and Yuliya Cherniavska advised Shire on Ukrainian components of US$2.4 billion oncology business sale to Servier S.A.S. The work mainly concerned transfer of rights for pegaspargase - a treatment for acute lymphoblastic leukemia being marketed in Ukraine and procured through international organization contracted by the Ministry of Health of Ukraine.

Borys Danevych and Anastasiia Filipiuk advised a top 10 global biopharmaceutical company on legal aspects of advertising, sponsorship and promotion with the use of logo of the company with Rx products portfolio in light of Ukrainian regulatory framework on advertising and promotion of Rx medicines, as well as industry codes.